Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Twist Bioscience Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Nektar Therapeutics June 5, 202492.1%
-
Twist Bioscience Corporation February 6, 202459.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Nektar Therapeutics | Grant or award | +2,000 | — | — |
| Aug 7, 2026 | Twist Bioscience Corporation | Option exercise | +18,417 | $11.89 | $218,978 |
| Aug 7, 2026 | Twist Bioscience Corporation | Open-market sale | −18,417 | $110.89 | $2,042,261 |
| Mar 17, 2026 | Twist Bioscience Corporation | Option exercise | +10,000 | $11.89 | $118,900 |
| Mar 17, 2026 | Twist Bioscience Corporation | Open-market sale | −10,000 | $47.00 | $470,000 |
| Feb 13, 2026 | Twist Bioscience Corporation | Open-market sale | −2,184 | $48.26 | $105,400 |
| Feb 5, 2026 | Twist Bioscience Corporation | Grant or award | +5,095 | — | — |
| Feb 7, 2025 | Twist Bioscience Corporation | Open-market sale | −2,940 | $53.14 | $156,232 |
| Feb 5, 2025 | Twist Bioscience Corporation | Grant or award | +4,472 | — | — |
| Jan 7, 2025 | Twist Bioscience Corporation | Open-market sale | −5,000 | $50.00 | $250,000 |
| Dec 5, 2024 | Twist Bioscience Corporation | Option exercise | +3,504 | $8.82 | $30,905 |
| Dec 5, 2024 | Twist Bioscience Corporation | Open-market sale | −2,795 | $51.70 | $144,502 |
| Dec 5, 2024 | Twist Bioscience Corporation | Open-market sale | −709 | $52.45 | $37,187 |
| Nov 11, 2024 | Twist Bioscience Corporation | Option exercise | +3,600 | $8.82 | $31,752 |
| Nov 11, 2024 | Twist Bioscience Corporation | Open-market sale | −2,324 | $46.99 | $109,205 |
Questions about Robert Chess
What boards is Robert Chess on?
Robert Chess sits on the boards of Nektar Therapeutics and Twist Bioscience Corporation.
How long has Robert Chess served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.